May 01, 2018
5:1
For every share held, investors received 5. The price per share adjusted from $102.40 to $20.48.
The split itself did not change the total investment value.
Genmab A/S (GMAB) trades on the NASDAQ Global Select in the Biotechnology industry.
Genmab A/S company overviewThe latest split shown was on May 1, 2018. It was a 5-for-1 forward split, so shareholders received 5 shares for every share they held.
This history records one forward split, on May 1, 2018.
Already premium? Sign in